AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SAF-HOLLAND SE

Investor Presentation Aug 13, 2020

6218_ip_2020-08-13_4bef11a1-ed93-455e-8f53-5a42d2f15e1e.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Financial results H1 2020

13 AUGUST 2020

AGENDA

Welcome

  • 1 Performance H1 2020 – Resilient business model pays off
  • 2 Outlook

Today's speakers – Welcome to our H1 2020 Financial Results Conference

Alexander Geis

Chairman of the Management Board (CEO)

  • CEO of the SAF-HOLLAND Group since February 26, 2019 and member of the Group Management Board since July 2011
  • With SAF-HOLLAND since 1995 and most recently President of the EMEA region and Chief Procurement Officer
  • Previously member of the Management Board and responsible for the Business Unit Aftermarket and for the strategic and operative alignment of the global spare parts business
  • MBA-degree of University of Maryland, USA

Alf Hospes

VP Group Treasury

  • With the company since 2007 and most recently Director Finance of the SAF-HOLLAND GmbH and VP Treasury and Accounting of the SAF-HOLLAND Group
  • Responsible for Finance and Controlling at SAF-HOLLAND GmbH and Group Treasury
  • Previously several other positions as Chief Accountant

1 Performance H1 2020 – Resilient business model pays off

Summary: Adjusted EBIT margin at the upper end of the guidance range

Truck and trailer production H1 2020 – COVID-19 strongly impacts already weakening markets

WESTERN &
EASTERN EUROPE
NORTH
AMERICA
CHINA SOUTH
AMERICA
INDIA
Truck Trailer Truck Trailer Truck Trailer Truck Trailer Truck Trailer
-45% to -50% -35% to -40% -50% -40% -25% -30% -20% -15% -45% -45%

Group – Positive adj. EBIT margin in Q2 despite very challenging market environment

  • Sales in H1 2020 influenced by market downturn and COVID-19
  • Acquisition effects (+0.2 per cent respectively € +1.6 mn)
  • FX effects (-0.1 per cent respectively € -0.8 mn)
  • Organic effects (-31.6 per cent respectively € -219.9 mn)

Adj. EBIT margin in H1 2020 affected by

  • Almost stable gross profit margin due to significantly higher share of high-margin aftermarket business
  • Fixed-cost progression effect (-)
  • Inventory write-downs (€ 5.6 mn) in the EMEA and Americas regions (-)
  • SG&A cost savings (+)

Restructuring expenses (€ 9.4 mn)

  • Severance payments (€ 2.7 mn)
  • Corpco wind-down (€ 2.2 mn)
  • Closure of subsidiaries (€ 1.8 mn)
  • Project FORWARD 2.0 (1.4 mn)
  • Change of legal form (€ 1.1 mn)

No goodwill impairments

EMEA – Robust adj. EBIT margin even in Q2

  • Sales in H1 2020 influenced by market downturn and COVID-19
  • Acquisition effects (+0.4 per cent respectively € +1.6 mn)
  • FX effects (-0.5 per cent respectively € -1.9 mn)
  • Organic effects (-22.9 per cent respectively € -79.8 mn)

Adj. EBIT margin in H1 2020 affected by

  • Improved gross profit margin (+)
  • Aftermarket business (+)
  • OE business (-)
  • Fixed-cost progression effect (-)
  • Inventory write-downs (€ 2.5 mn) as COVID-19 led to lower turnover rates (-)
  • SG&A cost savings (+)
  • Restructuring expenses (€ 2.2 mn) Mainly severance payments and costs related to the change of the legal form and transfer of the registered office to Germany (S.A. SE)

Americas – Slightly positive adj. EBIT margin in Q2 despite massive sales decline

  • Sales in H1 2020 massively influenced by market downturn and COVID-19
  • FX effects (+0.7 per cent respectively € +1.8 mn)
  • Organic effects (-36.8 per cent respectively € -100.3 mn)
  • Adj. EBIT margin in H1 2020 affected by
  • Lower gross profit margin (-)
    • Aftermarket business (+)
    • OE business (-)
  • Fixed-cost progression effect (-)
  • Inventory write downs (€ 3.3 mn) due to streamlining of the product portfolio and lower turnover rates due to COVID-19 (-)
  • SG&A cost savings (+)
  • Adj. EBIT margin in H1 2019 affected by
  • Contractually agreed passing on of the 2018 steel price increases (+)
  • Restructuring expenses (€ 2.6 mn) Mainly severance payments and costs related to Program FORWARD 2.0

APAC – Lockdown weighs on sales and profitability in Q2

  • Sales in H1 2020 massively influenced by market downturn and COVID-19
  • FX effects (-1.0 per cent respectively € -0.8 mn)
  • Organic effects (-53.3 per cent respectively € -39.9 mn) due to the several weeks lockdown of the Indian and Singapore entities, the ceased export business as a result of the trade dispute between China and the USA and the delayed ramp-up of the new Chinese facility in Yangzhou

Adj. EBIT margin in H1 2020 affected by

  • Significantly lower gross profit margin (-)
  • Aftermarket business (+)
  • OE business (-)
  • Special sale of old stock (-)
  • Volume effect still missing (-)
  • SG&A cost savings (+)
  • Restructuring expenses (€ 4.6 mn) Mainly costs related to Corpco wind-down and closure of subsidiaries

Investments and D&A – Disciplined investment policy is paying off

  • Investments in plant, property, equipment and intangible assets reached 2.5 per cent of Group sales (New FY 2020 guidance: around 2.5 per cent of Group sales)
  • Operating cash flow (4.7 cent of Group sales) covers investments by far
  • Focus of investments: Rationalisation investments in the US and Germany
  • Close monitoring of the investment approval process to streamline capital allocation
  • Depreciation and Amortization ratio (excl. PPA, impairment of goodwill and R&D projects) increased due to higher investments in recent years and lower sales

Net working capital – Cash-is-King program on track

Net working capital (NWC) 18.3 per cent or € 39.3 mn below previous year's figure

  • Inventories 21.2 per cent below prior year's level with a decrease in sales of 31.5 per cent
  • Trade receivables down 39.7 per cent on substantially improved cash collection
  • Trade payables down 46.3 per cent or € 69.9 mn compared to previous year's figure
  • NWC ratio increased from 15.9 per cent to 16.5 per cent due to market and corona related sales decline (LTM) of 21.4 per cent
  • Start of Cash-is-King program in April; already significant improvement in cash collection, further reduction of inventories in the remainder of the year

  • Operating free cash flow at € 11.2 mn (H1 2019: € 4.8 mn)

  • Operating cash flow at € 22.5 mn (H1 2019: € 27.6 mn)
  • Net investing cash flow at € -11.4 mn (PP&E and intangible assets) (H1 2019: € -22.8 mn)
  • Factoring volume at € 26.9 mn (H1 2019: € 39.3 mn)

NOTE: All figures shown are rounded, minor discrepancies may arise from additions of these amounts. * Operating Free Cash Flow = Net cash flow from operating activities less Net cash flow from investing activities (purchase of PP&E and intangible assets less proceeds from sales of PP&E); Operating free cash flow for Q1 2018 to Q4 2019 retrospectively adjusted according to the new definition

Net debt | Equity ratio – Solid financial profile

  • Gross liquidity of € 412.0 mn (cash and cash equivalents € 209.4 mn, undrawn credit lines € 202.6 mn) as of Jun 30, 2020 vs. gross liquidity of € 242.7 mn (cash and cash equivalents € 131.2 mn, undrawn credit lines € 111.5 mn) as of Dec 31, 2019
  • Cash and debt position temporarily influenced by cash inflow from promissory note (March 2020)
  • Cash inflow will be used to refinance the convertible bond that falls due on 12 September 2020 (volume: € 94.8 mn) and the 5-year tranches of the promissory note issued in November 2015 that falls due on 27 November 2020 (volume: € 52.0 mn).
  • Equity ratio temporarily influenced by balance sheet extension due to refinancing
WESTERN &
EASTERN EUROPE
NORTH
AMERICA
CHINA SOUTH
AMERICA
INDIA
Truck Trailer Truck Trailer Truck Trailer Truck Trailer Truck Trailer
New* -35% to
-40%
-20% New* -40% to
-50%
-40% to
-50%
New* -20% -25% New* -35% -15% New* -40% -40%
Old** -35% to
-40%
-20% Old** -40% to
-50%
-40% to
-50%
Old** -30% -40% Old** -30% -35% Old** -25% -30%

2020E:

  • Lower volumes in Europe, China and South America
  • Significant declines in North America and India
FY 2019 FY 2020*
Sales € 1,284 mn Decline by 20 to 30 per cent
Adj. EBIT margin 6.2
per cent
Between 3 and 5 per cent
CAPEX 4.1 per cent of sales Around 2.5 per cent of sales
(previously around 3 per
cent of sales)

* The forecast takes into account the foreseeable adverse effects on our business due to the coronavirus at the time of preparation (August 13, 2020). However, the economic effects on SAF-HOLLAND cannot currently be adequately determined or reliably quantified in full. The forecast is therefore subject to a high degree of uncertainty.

  • Consistent aftermarket business safeguards profitability
  • SG&A savings programs will be continued

Cash-is-King program on track

  • Solid financial profile
  • Operational excellence as key driver

Financial calendar & IR contact

DATE EVENT
09.09.2020 Hauck & Aufhäuser Virtual Roadshow
21.09.2020 Berenberg / Goldman Sachs
Virtual German Corporate Conference
14.10.2020 Jefferies European Mid-Cap Industrial Forum
10.11.2020 CIC Market Solutions Forum
18.11.2020 Quarterly Statement Q1-Q3 2020

25.11.2020 SAF-HOLLAND Virtual Investor & Analyst Day

Investor Relations Contact

Michael Schickling T: +49 (0) 6095 301 617 E: [email protected]

Alexander Pöschl T: +49 (0) 6095 301 117 E: [email protected]

Klaus Breitenbach T: + 49 (0) 6095 301 565 E: [email protected]

»WE ARE HAPPY TO ANSWER YOUR QUESTIONS.«

Appendix

P&L H1 2020 – Organisational and personnel adaption measures consistently executed

TEUR Q1-Q2/2020 Total
Adjustments
Q1-Q2/2020
adjusted*
in %
of sales
Q1-Q2/2019 Total
Adjustments
Q1-Q2/2019
adjusted*
in %
of sales
Sales 476,253 476,253 100.0% 695,466 695,466 100.0%
Cost of sales -398,550 6,524 -392,026 -82.3% -576,741 4,887 -571,854 -82.2%
Gross profit 77,703 6,524 84,227 17.7% 118,725 4,887 123,612 17.8%
Other income 803 -18 785 0.2% 715 715 0.1%
Other expenses 0.0% 0.0%
Impairment of goodwill 0.0% 0.0%
Selling expenses -28,758 4,040 -24,718 -5.1% -36,787 3,684 -33,103 -4.8%
Administrative expenses -32,914 3,501 -29,413 -6.2% -36,132 4,456 -31,676 -4.6%
Research and development costs -8,157 177 -7,980 -1.7% -10,728 172 -10,556 -1.5%
Operating profit 8,677 14,224 22,901 4.8% 35,793 13,199 48,992 7.0%
Share of net profit of investments
accounted for using the equity
method
754 754 0.2% 951 951 0.1%
EBIT 9,431 14,224 23,655 5.0% 36,744 13,199 49,943 7.2%
Depreciation & Amortization 22,996 -4,856 18,140 3.8% 20,862 -4,695 16,167 2.3%
EBITDA 32,427 9,368 41,795 8.8% 57,606 8,504 66,110 9.5%
Finance income 1,214 1,214 0.3% 701 701 0.1%
Finance expenses -7,327 -7,327 -1.5% -5,826 -5,826 -0.8%
Finance result -6,113 -6,113 -1.3% -5,125 -5,125 -0.7%
Result before taxes 3,318 14,224 17,542 3.7% 31,619 13,199 44,818 6.4%
Income taxes -1,640 -3,221 -4,861 -1.0% -10,851 -936 -11,787 -1.7%
Tax rate (%) 49.4% 27.7% 34.3% 26.3%
Result for the period 1,678 11,003 12,681 2.7% 20,768 12,263 33,030 4.7%

* Adjusted earnings correspond to the management perspective. The adjustments essentially include restructuring and transactions costs, write-off of goodwill, depreciation and amortization arising from purchase price allocations, expenses arising from the step-up of inventories arising from purchase price allocations and remeasurement effects related to call and put options.

Financial Results H1 2020 < 22 >

Adj. EBITDA margin

NOTE: All figures shown are rounded, minor discrepancies may arise from additions of these amounts.

Financial Results H1 2020 < 23 >

Adj. EBITDA margin

Product Amount
€ mn
Maturity
date
Convertible bond 94.8 09/2020
Promissory
note loan old (5 years)
52.0 11/2020
Promissory
note loan old (7 years)
5.0 11/2022
Promissory note loan new (3 years) 141.0 03/2023
Promissory note loan new (3.5 years) 20.0 11/2023
Promissory note loan new (5 years) 69 03/2025
Promissory note loan old (10 years) 9 10/2025
Revolving credit facility 200.0 10/2025
Non-current loan 50.0 06/2026
Promissory note loan new (7 years) 15 03/2027
Promissory
note loan new (10 years)
5 03/2030

Financial Results H1 2020 < 25 >

** option for an additional € 100 mn

• RCF mostly undrawn

Disclaimer

Not for general release, publication or distribution in the United States, Australia, Canada or Japan.

By attending this presentation you agree to be bound by the following limitations:

This presentation has been prepared by SAF-HOLLAND SE ("SAF-HOLLAND") and comprises written materials concerning SAF-HOLLAND. It is furnished to you solely for your information and may not be reproduced or redistributed, in whole or in part, to any other person. It contains summary information only and does not purport to be comprehensive and is not intended to be (and should not be used as) the sole basis of any analysis or other evaluation. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of any information, including projections, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and, accordingly, neither SAF-HOLLAND nor any of its directors, officers, employees or advisors nor any other person shall have any responsibility or liability whatsoever (for negligence or otherwise) arising, directly or indirectly, from the use of this presentation, or its contents or otherwise in connection with this presentation.

This presentation contains certain statements related to our future business and financial performance and future events or developments involving SAF-HOLLAND and/or the industry in which SAF-HOLLAND operates that may constitute forward-looking statements. These statements may be identified by words such as "believes," "expects," "predicts," "intends," "projects," "plans," "estimates," "aims," "foresees," "anticipates," "targets," and similar expressions. Forward-looking statements are not historical facts, but solely opinions, views and forecasts which are based on current expectations and certain assumptions of SAF-HOLLAND's management or cited from third party sources which are uncertain and subject to risks. Actual events may differ significantly from the anticipated developments due to a number of factors, including without limitation, changes in general economic conditions, changes affecting the fair values of the assets held by SAF-HOLLAND and its subsidiaries, changes affecting interest rate levels, changes in competition levels, changes in laws and regulations, environmental damages, the potential impact of legal proceedings and actions and the Group's ability to achieve operational synergies from past or future acquisitions. Should any of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove to be incorrect, actual results, performance or achievements of SAF-HOLLAND may (negatively or positively) vary materially from those described, explicitly or implicitly, in the relevant forward-looking statement.

The information contained in this presentation, including any forward-looking statements expressed herein, speaks only as of the date hereof and reflects current legislation and the business and financial affairs of the SAF-HOLLAND which are subject to change and audit. Neither the delivery of this presentation nor any further discussions of SAF-HOLLAND with any of the recipients thereof shall, under any circumstances, create any implication that there has been no change in the affairs of SAF-HOLLAND since such date. Consequently, SAF-HOLLAND neither accepts any responsibility for the future accuracy of the information contained in this presentation, including any forward-looking statements expressed herein, nor assumes any obligation, to update or revise this information to reflect subsequent events or developments which differ from those anticipated.

This presentation is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. This presentation is for information purposes only and does neither constitute an offer to sell securities, nor any recommendation of, or solicitation of an offer to buy, any securities of SAF-HOLLAND in the United States, Germany or any other jurisdiction. In the United States, any securities may not be offered or sold absent registration or an exemption from registration under the U.S. Securities Act of 1933.

Talk to a Data Expert

Have a question? We'll get back to you promptly.